Sanofi plans to invest around US$1.05 billion to build a new insulin production base in Beijing, which will mark the French ...
In a bid to bolster pandemic preparedness, Sanofi has opened a modular vaccine manufacturing plant in Tuas Biomedical Park, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback